Related Experiment Video

Updated: Jul 3, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Prognostic relevance of coronary collateral circulation: clinical and epidemiological implications

Okan Turgut, Mehmet Birhan Yilmaz, Kenan Yalta

    International Journal of Cardiology
    |August 8, 2008
    PubMed

    Insights

    Coronary collateral circulation is crucial for ischemic heart disease, influencing damage severity. Understanding its determinants could clarify its role in cardiovascular risk and prognosis.

    Area of Science:

    • Cardiovascular Medicine
    • Ischemic Heart Disease Research
    • Atherosclerosis Studies

    Background:

    • Coronary collateral circulation (CCC) is a vital compensatory mechanism in ischemic heart disease, impacting myocardial damage severity.
    • The clinical significance of CCC remains debated due to challenges in measurement and limited patient representation in studies.
    • Prognosis in ischemic heart disease may depend on the interplay between atherosclerotic burden and CCC benefits.

    Discussion:

    • Atherosclerosis triggers CCC formation but also contributes to cardiovascular morbidity and mortality.
    • CCC plays a complex role in modulating cardiovascular risk in patients with ischemic heart disease.
    • Further research into CCC determinants is essential for clinical and epidemiological applications.

    Key Insights:

    • CCC partially dictates the extent of ischemic myocardial damage.
    • The balance between atherosclerotic harm and CCC benefit influences patient prognosis.
    • Understanding CCC's role is key to managing cardiovascular risk.

    Outlook:

    • Elucidating CCC determinants will enhance clinical risk stratification.
    • Improved insights into CCC can refine epidemiological assessments of heart disease.
    • Future research should focus on precise CCC evaluation and its prognostic implications.

    Related Concept Videos

    Coronary Artery Disease III: Clinical Manifestations01:30

    Coronary Artery Disease III: Clinical Manifestations

    Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
    Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

    Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

    The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
    Acute Coronary Syndrome III: Diagnostic Studies01:30

    Acute Coronary Syndrome III: Diagnostic Studies

    Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
    Coronary Artery Disease II: Pathophysiology01:26

    Coronary Artery Disease II: Pathophysiology

    Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
    Coronary Artery Disease V: Interprofessional Care01:27

    Coronary Artery Disease V: Interprofessional Care

    Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
    Coronary Artery Disease I: Introduction01:30

    Coronary Artery Disease I: Introduction

    Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...